Linked Life Data

15277264

Source:http://linkedlifedata.com/resource/pubmed/id/15277264

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2004-7-27
pubmed:abstractText
Fatigue is a frequent and severe problem after treatment of patients with hematological malignancies. This symptom has been associated with anemia, reduced physical performance, mood, endocrine disorders and impaired nutritional status. Recently, it has been suggested that fatigue can be related to a persistent activation of the immune system with increased production of proinflammatory cytokines. However, there is no conclusive evidence regarding the role of the immune system in the origin of fatigue in cancer patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0923-7534
pubmed:author
pubmed:copyrightInfo
Copyright 2004 European Society for Medical Oncology
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1237-42
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment.
pubmed:affiliation
Institute of Sports Medicine, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany. fernando.dimeo@chante.de
pubmed:publicationType
Journal Article